International Journal of Pharmaceutics, 493 (1-2), 460-465
Cartilage-specific targeting Why cartilage needs support: Cartilage has no blood supply (avascular) Nutrients diffuse slowly from synovial fluid Healing extremely slow (6-12+ months) Degenerates with age and use Poor regenerative capacity naturally Cartilage structure: Chondrocytes: Cartilage cells (only 1-5% of volume) Extracellular matrix: 95-99% of cartilage Collagen Type II (structure) Proteoglycans (water retention, cushioning) Water (65-80% of weight) Provides smooth, low-friction joint surface Absorbs compressive forces Age-related cartilage changes: Chondrocyte activity declines (less matrix production) Collagen degradation exceeds synthesis Water content decreases (less cushioning) Inflammatory markers increase Net result: Joint degeneration How Cartalax targets cartilage: Specific uptake by chondrocytes Gene regulation in cartilage cells Restores cartilage matrix balance Reduces age-related decline Conditions potentially helped: Osteoarthritis (cartilage wear) Age-related joint stiffness Post-injury cartilage damage Athletic overuse Preventive joint maintenance See best peptides for joint pain for comprehensive options
Insert the needle through the stopper and push the air in
TB-500 works differently
Vitamin Injections deliver superior, rapid-acting benefits you cant get from pills or powdersmaximizing absorption, efficiency, and wellness support
BPC-157, which is short for Body Protection Compound 157, was discovered in human gastric juice in a lab led by Predrag Sikiric, a Croatian scientist
